Susquehanna Fundamental Investments, LLC Sellas Life Sciences Group, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.38 $23,646 - $39,566	-11,706 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.73 - $7.18 $50,819 - $77,141	-10,744 Reduced 47.86%	11,706 $78,000
Q4 2021 Feb 14, 2022	SELL	$5.36 - $9.53 $31,784 - $56,512	-5,930 Reduced 20.89%	22,450 $124,000
Q3 2021 Nov 15, 2021	BUY	$8.21 - $10.53 $232,999 - $298,841	28,380 New	28,380 $260,000

4.37M

3.28M

56.3K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $24.7M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.